Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Retinoblastoma”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Ended earlyNCT01857752
What this trial is testing

Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala

Who this might be right for
Retinoblastoma
Stanford University 3
Early research (Phase 1)Looking for participantsNCT05650749
What this trial is testing

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-risk Neuroblastoma+2 more
Stephan Grupp MD PhD 45
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006102
What this trial is testing

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Ended earlyNCT03130439
What this trial is testing

Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 27
Testing effectiveness (Phase 2)WithdrawnNCT00003273
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more
NYU Langone Health
Large-scale testing (Phase 3)Study completedNCT00554788
What this trial is testing

Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma

Who this might be right for
Extraocular Retinoblastoma
Children's Oncology Group 60
Testing effectiveness (Phase 2)Looking for participantsNCT06498648
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Who this might be right for
Advanced Dedifferentiated LiposarcomaAdvanced LeiomyosarcomaAdvanced Soft Tissue Sarcoma+5 more
National Cancer Institute (NCI) 74
Not applicableActive Not RecruitingNCT06725173
What this trial is testing

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Who this might be right for
Retinoblastoma BilateralRetinoblastoma UnilateralRetinoblastoma, Extraocular+2 more
University of Washington 100
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)Study completedNCT00004006
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma

Who this might be right for
Retinoblastoma
St. Jude Children's Research Hospital 4
Not applicableStudy completedNCT00690469
What this trial is testing

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Who this might be right for
Extraocular RetinoblastomaIntraocular RetinoblastomaRecurrent Retinoblastoma
Children's Oncology Group 234
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Large-scale testing (Phase 3)Study completedNCT03475121
What this trial is testing

Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma

Who this might be right for
Unilateral Retinoblastoma
Hospital JP Garrahan 84
Not applicableLooking for participantsNCT04903678
What this trial is testing

Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma

Who this might be right for
Retinoblastoma, Extraocular
Eye & ENT Hospital of Fudan University 18
Early research (Phase 1)Study completedNCT01320592
What this trial is testing

PD0332991/Paclitaxel in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 28
Not applicableStudy completedNCT04164134
What this trial is testing

New Strategies to Detect Cancers in Carriers of Mutations in RB1

Who this might be right for
RetinoblastomaSecondary Primary Malignancies After Retinoblastoma
Amsterdam UMC, location VUmc 378
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Active Not RecruitingNCT03567642
What this trial is testing

The Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 11
Early research (Phase 1)Looking for participantsNCT06577987
What this trial is testing

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorRefractory Solid Tumor+7 more
Circle Pharma 220
Load More Results